Allosteric modulation of ligand-gated ion channels

Biochemical Pharmacology

Volumn 70, Issue 9, 2005, Pages 1267-1276

  Hogg, Ron C ^a   Buisson, Bruno ^b   Bertrand, Daniel ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b Trophos SA   (France)

Author keywords

Allosteric modulation; Divalent cations; Glutamate receptors; Ligand gated ion channels; nAChRs; Nicotinic acetylcholine receptors; P2X receptors

Indexed keywords

CELL SURFACE PROTEIN; INTRINSIC FACTOR; NEUROTRANSMITTER;

ALLOSTERISM; CELL ACTIVITY; CELL STIMULATION; CHANNEL GATING; CONCENTRATION RESPONSE; DEPOLARIZATION; DRUG DESIGN; ELECTRIC CURRENT; EXCITABILITY; HYPERPOLARIZATION; ION CURRENT; LIGAND BINDING; PH; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SURFACE CHARGE; SYNAPTIC TRANSMISSION;

EID: 25844502439     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2005.06.010     Document Type: Note

References (69)

1. P. Illes, and J. Alexandre Ribeiro Molecular physiology of P2 receptors in the central nervous system Eur J Pharmacol 483 1 2004 5 17
2. R.A. North P2X3 receptors and peripheral pain mechanisms J Physiol 554 Pt 2 2004 301 308
3. G. Burnstock Introduction: P2 receptors Curr Top Med Chem 4 8 2004 793 803
4. R.A. North Molecular physiology of P2X receptors Physiol Rev 82 4 2002 1013 1067
5. R. Dingledine, K. Borges, D. Bowie, and S.F. Traynelis The glutamate receptor ion channels Pharmacol Rev 51 1 1999 7 61
6. M.J. O'Neill, D. Bleakman, D.M. Zimmerman, and E.S. Nisenbaum AMPA receptor potentiators for the treatment of CNS disorders Curr Drug Targets CNS Neurol Disord 3 3 2004 181 194
7. R.B. Puchalski, J.C. Louis, N. Brose, S.F. Traynelis, J. Egebjerg, and V. Kukekov Selective RNA editing and subunit assembly of native glutamate receptors Neuron 13 1 1994 131 147
8. D.E. Koshland Jr., G. Nemethy, and D. Filmer Comparison of experimental binding data and theoretical models in proteins containing subunits Biochemistry 5 1 1966 365 385
9. J. Monod, J. Wyman, and J.P. Changeux On the nature of allosteric transitions: a plausible model J Mol Biol 12 1965 88 118
10. A. Karlin On the application of "a plausible model" of allosteric proteins to the receptor for acetylcholine J Theor Biol 16 2 1967 306 320
11. T. Nakagawa, Y. Cheng, E. Ramm, M. Sheng, and T. Walz Structure and different conformational states of native AMPA receptor complexes Nature 433 7025 2005 545 549
12. W. Soudijn, I. van Wijngaarden, and I.J. AP Allosteric modulation of G protein-coupled receptors Curr Opin Drug Discov Dev 5 5 2002 749 755
13. A. Christopoulos Allosteric binding sites on cell-surface receptors: novel targets for drug discovery Nat Rev Drug Discov 1 3 2002 198 210
14. T. Kenakin Efficacy at G-protein-coupled receptors Nat Rev Drug Discov 1 2 2002 103 110
15. J.L. Galzi, S.J. Edelstein, and J. Changeux The multiple phenotypes of allosteric receptor mutants Proc Natl Acad Sci USA 93 5 1996 1853 1858
16. K.S. Jones, H.M. VanDongen, and A.M. VanDongen The NMDA receptor M3 segment is a conserved transduction element coupling ligand binding to channel opening J Neurosci 22 6 2002 2044 2053
17. L. Matsson, V. Sa-yakanit, and S. Boribarn Ligand-gated ion channel currents in a nonstationary lyotropic model Neurochem Res 28 2 2003 379 386
18. J.P. Dilger The effects of general anaesthetics on ligand-gated ion channels Br J Anaesth 89 1 2002 41 51
19. J.C. Quirk, and E.S. Nisenbaum Multiple molecular determinants for allosteric modulation of alternatively spliced AMPA receptors J Neurosci 23 34 2003 10953 10962
20. P. Miu, K.R. Jarvie, V. Radhakrishnan, M.R. Gates, A. Ogden, and P.L. Ornstein Novel AMPA receptor potentiators LY392098 and LY404187: effects on recombinant human AMPA receptors in vitro Neuropharmacology 40 8 2001 976 983
21. 2+ on rat DRG neurons in culture Neuropharmacology 44 1 2003 132 140
22. C. Coddou, B. Morales, and J.P. Huidobro-Toro Neuromodulator role of zinc and copper during prolonged ATP applications to P2X4 purinoceptors Eur J Pharmacol 472 1-2 2003 49 56
23. R. Kanjhan, N.P. Raybould, D.J. Jagger, D. Greenwood, and G.D. Housley Allosteric modulation of native cochlear P2X receptors: insights from comparison with recombinant P2X2 receptors Audiol Neurootol 8 3 2003 115 128
24. A. Surprenant Functional properties of native and cloned P2X receptors Ciba Found Symp 198 1996 208 219 [Discussion 219-22]
25. K. Alexander, W. Niforatos, B. Bianchi, E.C. Burgard, K.J. Lynch, and E.A. Kowaluk Allosteric modulation and accelerated resensitization of human P2X(3) receptors by cibacron blue J Pharmacol Exp Ther 291 3 1999 1135 1142
26. B.S. Khakh, W.R. Proctor, T.V. Dunwiddie, C. Labarca, and H.A. Lester Allosteric control of gating and kinetics at P2X(4) receptor channels J Neurosci 19 17 1999 7289 7299
27. M.P. Regalado, A. Villarroel, and J. Lerma Intersubunit cooperativity in the NMDA receptor Neuron 32 6 2001 1085 1096
28. J.A. Kemp, and R.M. McKernan NMDA receptor pathways as drug targets. Nat Neurosci 5 Suppl 2002 1039 1042
29. J. Krusek, I. Dittert, T. Hendrych, P. Hnik, M. Horak, and M. Petrovic Activation and modulation of ligand-gated ion channels Physiol Res 53 Suppl 1 2004 S103 S113
30. J. Rachline, F. Perin-Dureau, A. Le Goff, J. Neyton, and P. Paoletti The micromolar zinc-binding domain on the NMDA receptor subunit NR2B J Neurosci 25 2 2005 308 317
31. F. Perin-Dureau, J. Rachline, J. Neyton, and P. Paoletti Mapping the binding site of the neuroprotectant ifenprodil on NMDA receptors J Neurosci 22 14 2002 5955 5965
32. J. Ruel, M.J. Guitton, and J.L. Puell Negative allosteric modulation of AMPA-preferring receptors by the selective isomer GYKI 53784 (LY303070), a specific non-competitive AMPA antagonist CNS Drug Rev 8 3 2002 235 254
33. J.P. Changeux, and S.J. Edelstein Allosteric receptors after 30 years Neuron 21 5 1998 959 980
34. R.M. Krause, B. Buisson, S. Bertrand, P.J. Corringer, J.L. Galzi, and J.P. Changeux Ivermectin: a positive allosteric effector of the alpha7 neuronal nicotinic acetylcholine receptor Mol Pharmacol 53 2 1998 283 294
35. R. Zwart, G. De Filippi, L.M. Broad, G.I. McPhie, K.H. Pearson, and T. Baldwinson 5-Hydroxyindole potentiates human alpha 7 nicotinic receptor-mediated responses and enhances acetylcholine-induced glutamate release in cerebellar slices Neuropharmacology 43 3 2002 374 384
36. L. Curtis, B. Buisson, S. Bertrand, and D. Bertrand Potentiation of human alpha4beta2 neuronal nicotinic acetylcholine receptor by estradiol Mol Pharmacol 61 1 2002 127 135
37. M.J. Dart, J.T. Wasicak, K.B. Ryther, M.R. Schrimpf, K.H. Kim, and D.J. Anderson Structural aspects of high affinity ligands for the alpha 4 beta 2 neuronal nicotinic receptor Pharm Acta Helv 74 2-3 2000 115 123
38. R.S. Hurst, M. Hajos, M. Raggenbass, T.M. Wall, N.R. Higdon, and J.A. Lawson A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization J Neurosci 25 17 2005 4396 4405
39. M. Samochocki, M. Zerlin, R. Jostock, P.J. Groot Kormelink, W.H. Luyten, and E.X. Albuquerque Galantamine is an allosterically potentiating ligand of the human alpha4/beta2 nAChR Acta Neurol Scand Suppl 176 2000 68 73
40. L. Texido, E. Ros, M. Martin-Satue, S. Lopez, J. Aleu, and J. Marsal Effect of galantamine on the human alpha7 neuronal nicotinic acetylcholine receptor, the Torpedo nicotinic acetylcholine receptor and spontaneous cholinergic synaptic activity Br J Pharmacol 2005
41. E.X. Albuquerque, M.D. Santos, M. Alkondon, E.F. Pereira, and A. Maelicke Modulation of nicotinic receptor activity in the central nervous system: a novel approach to the treatment of Alzheimer disease Alzheimer Dis Assoc Disord 15 Suppl 1 2001 S19 S25
42. A. Maelicke, and E.X. Albuquerque Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's disease Eur J Pharmacol 393 1-3 2000 165 170
43. S. Valera, M. Ballivet, and D. Bertrand Progesterone modulates a neuronal nicotinic acetylcholine receptor Proc Natl Acad Sci USA 89 20 1992 9949 9953
44. K. Paradiso, J. Zhang, and J.H. Steinbach The C terminus of the human nicotinic alpha4beta2 receptor forms a binding site required for potentiation by an estrogenic steroid J Neurosci 21 17 2001 6561 6568
45. C. Bouzat, and F.J. Barrantes Modulation of muscle nicotinic acetylcholine receptors by the glucocorticoid hydrocortisone. Possible allosteric mechanism of channel blockade J Biol Chem 271 42 1996 25835 25841
46. I. Garbus, C. Bouzat, and F.J. Barrantes Steroids differentially inhibit the nicotinic acetylcholine receptor Neuroreport 12 2 2001 227 231
47. L. Ke, and R.J. Lukas Effects of steroid exposure on ligand binding and functional activities of diverse nicotinic acetylcholine receptor subtypes J Neurochem 67 3 1996 1100 1112
48. L. Koles, K. Wirkner, and P. Illes Modulation of ionotropic glutamate receptor channels Neurochem Res 26 8-9 2001 925 932
49. C. Moon, S.P. Fraser, and M.B. Djamgoz Protein kinase and phosphatase modulation of quail brain GABA(A) and non-NMDA receptors co-expressed in Xenopus oocytes Cell Signal 12 2 2000 105 112
50. S.L. Swope, S.J. Moss, C.D. Blackstone, and R.L. Huganir Phosphorylation of ligand-gated ion channels: a possible mode of synaptic plasticity FASEB J 6 8 1992 2514 2523
51. J.M. Miwa, I. Ibanez-Tallon, G.W. Crabtree, R. Sanchez, A. Sali, and L.W. Role Lynx1, an endogenous toxin-like modulator of nicotinic acetylcholine receptors in the mammalian CNS Neuron 23 1 1999 105 114
52. I. Ibanez-Tallon, J.M. Miwa, H.L. Wang, N.C. Adams, G.W. Crabtree, and S.M. Sine Novel modulation of neuronal nicotinic acetylcholine receptors by association with the endogenous prototoxin lynx1 Neuron 33 6 2002 893 903
53. F. Chimienti, R.C. Hogg, L. Plantard, C. Lehmann, N. Brakch, and J. Fischer Identification of SLURP-1 as an epidermal neuromodulator explains the clinical phenotype of Mal de Meleda Hum Mol Genet 12 22 2003 3017 3024
54. R. Mastrangeli, S. Donini, C.A. Kelton, C. He, A. Bressan, and F. Milazzo ARS Component B: structural characterization, tissue expression and regulation of the gene and protein (SLURP-1) associated with Mal de Meleda Eur J Dermatol 13 6 2003 560 570
55. A. Schrattenholz, E.F. Pereira, U. Roth, K.H. Weber, E.X. Albuquerque, and A. Maelicke Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands Mol Pharmacol 49 1 1996 1 6
56. K. Brejc, W.J. van Dijk, R.V. Klaassen, M. Schuurmans, J. van Der Oost, and A.B. Smit Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors Nature 411 6835 2001 269 276
57. U. Rudolph, F. Crestani, D. Benke, I. Brunig, J.A. Benson, and J.M. Fritschy Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes Nature 401 6755 1999 796 800
58. H. Mohler, J.M. Fritschy, F. Crestani, T. Hensch, and U. Rudolph Specific GABA(A) circuits in brain development and therapy Biochem Pharmacol 68 8 2004 1685 1690
59. H. Mohler, W. Sieghart, J.G. Richards, and W. Hunkeler Photoaffinity labeling of benzodiazepine receptors with a partial inverse agonist Eur J Pharmacol 102 1 1984 191 192
60. E. Costa, J. Auta, D.R. Grayson, K. Matsumoto, G.D. Pappas, and X. Zhang GABAA receptors and benzodiazepines: a role for dendritic resident subunit mRNAs Neuropharmacology 43 6 2002 925 937
61. E. Sigel, and A. Buhr The benzodiazepine binding site of GABAA receptors Trends Pharmacol Sci 18 11 1997 425 429
62. D. Berezhnoy, R. Baur, A. Gonthier, B. Foucaud, M. Goeldner, and E. Sigel Conformational changes at benzodiazepine binding sites of GABA receptors detected with a novel technique J Neurochem 92 4 2005 859 866
63. R.W. Olsen, C.S. Chang, G. Li, H.J. Hanchar, and M. Wallner Fishing for allosteric sites on GABA(A) receptors Biochem Pharmacol 68 8 2004 1675 1684
64. J.J. Lambert, D. Belelli, D.R. Peden, A.W. Vardy, and J.A. Peters Neurosteroid modulation of GABAA receptors Prog Neurobiol 71 1 2003 67 80
65. S. Ueno, M. Tsutsui, Y. Toyohira, K. Minami, and N. Yanagihara Sites of positive allosteric modulation by neurosteroids on ionotropic gamma-aminobutyric acid receptor subunits FEBS Lett 566 1-3 2004 213 217
66. M. Williams, and E.A. Risley Ivermectin interactions with benzodiazepine receptors in rat cortex and cerebellum in vitro J Neurochem 42 3 1984 745 753
67. G.R. Dawson, K.A. Wafford, A. Smith, G.R. Marshall, P.J. Bayley, and J.M. Schaeffer Anticonvulsant and adverse effects of avermectin analogs in mice are mediated through the gamma-aminobutyric acid(A) receptor J Pharmacol Exp Ther 295 3 2000 1051 1060
68. J. Krusek, and H. Zemkova Effect of ivermectin on gamma-aminobutyric acid-induced chloride currents in mouse hippocampal embryonic neurones Eur J Pharmacol 259 2 1994 121 128
69. M.J. O'Neill, T.K. Murray, K. Whalley, M.A. Ward, C.A. Hicks, and S. Woodhouse Neurotrophic actions of the novel AMPA receptor potentiator, LY404187, in rodent models of Parkinson's disease Eur J Pharmacol 486 2 2004 163 174